Our Experts
Physician Profile
412-692-7192
Phone
412-692-7693
Fax
Lakshmanan Krishnamurti, MD
Job Title
Director, Comprehensive Hemoglobinopathy Program
4401 Penn Avenue, Suite Floor 9
Pittsburgh,
PA
15224
412-692-7192
Phone
412-692-7693
Fax
Education and Training
|
Medical School: |
1987 Naval Hospital, Bombay University, Bombay, India |
|
Residency: |
1998 University of Minnesota, Minneapolis, MN |
|
Fellowship: |
1997 University of Minnesota, Minneapolis, MN |
Memberships
- American Society of Hematology
- American Society of Pediatric Hematology/Oncology
- American Society of Bone Marrow Transplantation
Board Certifications
- American Board of Pediatrics
- American Board of Pediatrics, Sub-board of Pediatric Hematology/Oncology
Awards
- "Ajit Gharpure Award" for excellence in Preventive Medicine and Public Health, Poona University, Pune, India
Publications
- Health beliefs among African American women regarding genetic testing and counseling for sickle cell disease.
Gustafson SL, Gettig EA, Watt-Morse M, Krishnamurti L
Genet Med
Research Interests
- Hemoglobinopathies clinical and molecular epidemiologic aspects
- Newborn screening and counseling for hemoglobinopathies
- Novel approaches to hematopoietic stem cell transplantation for hemoglobinopathies
- Lymphoproliferative disorder following solid organ and bone marrow transplantation
- Non-myeloablative HSCT for malignant and non-malignant disorders
- Role of allochimerism in tolerization to transplanted solid organs
- Role of Bioinformatics systems in clinical care and research in sickle cell disease
Active Research Projects / Grants
- Principal Investigator, A Phase II/II study of Sildenafil for the treatment of sickle cell disease, associated pulmonary hypertension
- Principal Investigator, "Western Pennsylvania Sickle Cell Network: An Integrated System of Care for the Enhancement of Newborn Screening Follow-Up"
- Principal Investigator, "Newborn Screening Follow-Up and comprehensive care for Sickle cell disease in region 3 of Pennsylvania"
- Site Principal Investigator, "Deferoxamine in sickle cell disease patients with transfusional hemosiderosis"
- Site Principal Investigator, "Safety of ICL670 in Sickle Cell Patients with Iron Overload"
- Site Principal Investigator, "Safety of ICA-17043 with or without Hydroxyurea"
- Site Principal Investigator, "Randomized study of Inhaled Nitric Oxide for the treatment of sickle cell associated vasocclusive pain crises"
